These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32989258)

  • 1. Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.
    Wang G; Wang J; Chang A; Cheng D; Huang S; Wu D; Sirkisoon S; Yang S; Lin HK; Lo HW; Xiang R; Sun P
    Oncogene; 2020 Nov; 39(47):7034-7050. PubMed ID: 32989258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition.
    Wang J; Wang G; Cheng D; Huang S; Chang A; Tan X; Wang Q; Zhao S; Wu D; Liu AT; Yang S; Xiang R; Sun P
    Oncogene; 2020 Oct; 39(40):6313-6326. PubMed ID: 32848211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
    Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
    Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCF(Skp2) proteasomal complex.
    Bhatt S; Xiao Z; Meng Z; Katzenellenbogen BS
    Mol Cell Biol; 2012 May; 32(10):1928-43. PubMed ID: 22431515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin.
    Sun SH; Huang HC; Huang C; Lin JK
    Eur J Pharmacol; 2012 Sep; 690(1-3):22-30. PubMed ID: 22705896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
    Zuo T; Liu R; Zhang H; Chang X; Liu Y; Wang L; Zheng P; Liu Y
    J Clin Invest; 2007 Dec; 117(12):3765-73. PubMed ID: 18008005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation.
    Senger K; Pham VC; Varfolomeev E; Hackney JA; Corzo CA; Collier J; Lau VWC; Huang Z; Hamidzhadeh K; Caplazi P; Peng I; Setiadi AF; Francis R; Paler-Martinez A; Kwon YC; Ramirez-Carrozzi V; Sun Y; Grigg PW; Roose-Girma M; Jeet S; Barck KH; Pham A; Ota N; Ha C; Stinson J; Guillory J; Tam L; Modrusan Z; Emson C; McKenzie BS; Townsend MJ; Carano RAD; Warming S; Vucic D; DeVoss J; Lee WP; Lill JR; Zarrin AA
    Sci Signal; 2017 Apr; 10(475):. PubMed ID: 28420753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activation of P38 MAP kinase in invasive ductal breast cancers: correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins.
    Merlin JL; Harlé A; Lion M; Ramacci C; Leroux A
    Oncol Rep; 2013 Oct; 30(4):1943-8. PubMed ID: 23900300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
    Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
    Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to: Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.
    Wang G; Wang J; Chang A; Cheng D; Huang S; Wu D; Sirkisoon S; Yang S; Lin HK; Lo HW; Xiang R; Sun P
    Oncogene; 2021 Mar; 40(12):2335. PubMed ID: 33568787
    [No Abstract]   [Full Text] [Related]  

  • 14. Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.
    Das S; Sondarva G; Viswakarma N; Nair RS; Osipo C; Tzivion G; Rana B; Rana A
    J Biol Chem; 2015 Aug; 290(35):21705-12. PubMed ID: 26152725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.
    Liu J; Wei XL; Huang WH; Chen CF; Bai JW; Zhang GJ
    PLoS One; 2012; 7(12):e52675. PubMed ID: 23300741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Way TD; Kao MC; Lin JK
    J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
    Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
    Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tyrosine kinase Syk regulates TPL2 activation signals.
    Eliopoulos AG; Das S; Tsichlis PN
    J Biol Chem; 2006 Jan; 281(3):1371-80. PubMed ID: 16291755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell adhesion tunes inflammatory TPL2 kinase signal transduction.
    Vougioukalaki M; Georgila K; Athanasiadis EI; Eliopoulos AG
    Cell Mol Life Sci; 2022 Feb; 79(3):156. PubMed ID: 35218437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.